Abstract
Several studies have reported that a variant allele (S2) of the apolipoprotein (apo) A-I/C-III/A-IV complex is associated with hyperlipoproteinemia in some populations and that the frequency of this allele is two- to fivefold higher in patients with premature coronary heart disease (CHD) than in healthy controls. In the present study in a Japanese population, we were unable to confirm the association of the S2 allele with either coronary heart disease or elevated serum apo C-III levels, as has been previously reported in Caucasians. No genotype difference was observed among the severity of coronary heart disease, as determined by the number of involved vessels (one, two and three vessel disease), compared to controls. In addition, the frequency of the S2 allele among Japanese, in both CHD (0.328) and controls (0.369), was quite different from that in many other populations.
This is a preview of subscription content, log in via an institution to check access.
References
Allain CC, Poon LS, Chan CS (1974) Enzymatic determination of total cholesterol. Clin Chem 20: 470–475
Eggestein M, Kreuntz FH (1966) Eine neue Bestimmung der Neutralfette in Blutserum und Gewebe. I. Mitt. Prinzip, Durchführung und Besprechung der Methode. Klin Wochenschr 44: 262
Erlich HA (1989) PCR technology: principles and applications for DNA amplification, 1st edn. Stockton Press, New York
Ferns GAA, Ritchie C, Stocks J, Galton DJ (1985) Genetic polymorphisms of apolipoprotein C-III and insulin in survivors of myocardial infarction. Lancet II: 300–303
Ikeda T, Shibuya U, Sugiuchi H, Araki S, Uji Y, Okabe H (1991) Automated immunoturbidimetric analysis of six plasma apolipoproteins: correlation with radial immunodiffusion assays. J Clin Lab Anal 5: 90–95
Karathanasis SK, ZanniS VI, Breslow JL (1985) Isolation and characterization of cDNA clones corresponding to two different apo C-III alleles. J Lipid Res 26: 451–456
Noma A, Nezu-Nakayama K, Kita M, Okabe H (1978) Simultaneous determination of serum cholesterol in high- and low-density lipoproteins with use of heparin Ca2+, and anion-exchange resin. Clin Chem 24: 1504–1508
O'Connor G, Stocks J, Lumley J, Galton DJ (1987) A DNA polymorphism of the apolipoprotein C-III gene in extracoronary atherosclerosis. Clin Sci 74: 289–292
Paul H, Galton D, Stocks J (1987) DNA polymorphic patterns and haplotype arrangements of the apo A-I, apo C-III, apo A-IV gene cluster in different ethnic groups. Hum Genet 75: 267–268
Price WH, Morris SW, Kitchen AH, Wenham PR, Burgon PRS. Donald PM (1989) DNA restriction fragment length polymorphisms as markers of familial coronary heart disease. Lancet I: 1407–1411
Rees A, Stocks J, Sharpe CR, Vella MA, Shoulders CC, Katz J, Jowett NI, Baralle FE, Galton DJ.(1985a) Deoxyribonucleic acid polymorphism in the apolipoprotein A-I-C-III gene cluster: association with hypertriglyceridemia. J Clin Invest 76: 1090–1095
Rees A, Stocks J, Williams LG, Caplin JL, Jowett NI, Camm AJ, Galton DJ. (1985b) DNA polymorphisms in the apolipoprotein C-III and insulin genes and atherosclerosis. Atherosclerosis 58: 269–275
Rees A, Stocks J, Paul H, Ohuchi Y, Galton D (1986) Haplotypes identified by DNA polymorphisms at the apolipoprotein A-I and C-III loci and hypertriglyceridemia: a study in a Japanese opulation. Hum Genet 72: 168–171
Shoulders CC, Harry PJ, Lagrost L, White SE, Shah NF, North JD. Gilligan M, Gambert P, Ball MJ (1991) Variation at the apo AI/CIII/AIV gene complex is associated with elevated plasma levels of apo CIII. Atherosclerosis 87: 239–247
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bai, H., Saku, K., Liu, R. et al. Association between coronary heart disease and the apolipoprotein A-I/C-III/A-IV complex in a Japanese population. Hum Genet 95, 102–104 (1995). https://doi.org/10.1007/BF00225084
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00225084